相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rabbit Anti-T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation
Jan Storek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease
Kenneth F. Bradstock et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
High Fever Occurring 4 to 5 Days Post-Transplant of Haploidentical Bone Marrow or Peripheral Blood Stem Cells after Reduced-Intensity Conditioning Associated with the Use of Post-Transplant Cyclophosphamide as Prophylaxis for Graft-versus-Host Disease
Paul O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A Two-Step Approach to Myeloablative Haploidentical Transplantation: Low Nonrelapse Mortality and High Survival Confirmed in Patients with Earlier Stage Disease
Dolores Grosso et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies
Amin M. Alousi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Haploidentical Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Huan Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Yu Wang et al.
BLOOD (2015)
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S. Garciaz et al.
BONE MARROW TRANSPLANTATION (2015)
Donor HLA-specific Abs: to BMT or not to BMT?
M. S. Leffell et al.
BONE MARROW TRANSPLANTATION (2015)
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies
Jean El-Cheikh et al.
CANCER (2015)
Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells
Jan J. Melenhorst et al.
MOLECULAR THERAPY (2015)
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
R. Crocchiolo et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants
Joseph R. Leventhal et al.
TRANSPLANTATION (2015)
Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL
Y-Q Sun et al.
BONE MARROW TRANSPLANTATION (2015)
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: No difference in the high-and low-risk groups
Xiao-Dong Mo et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
J. Peccatori et al.
LEUKEMIA (2015)
Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning
Kavita Raj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Are Alternative Donors Really Still Alternative?
Christopher G. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies
Mary Eapen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen Matched Unrelated and Related Donors
Antonio Di Stasi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide
Luca Castagna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Rarity of Donor-Derived Malignancy after Allogeneic BMT with High-Dose Post-Transplantation Cyclophosphamide
Heather Jill Symons et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
Sudipto Ganguly et al.
BLOOD (2014)
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
Yi Luo et al.
BLOOD (2014)
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G. Kanakry et al.
BLOOD (2014)
Who is the best donor for a related HLA haplotype-mismatched transplant?
Yu Wang et al.
BLOOD (2014)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina et al.
BLOOD (2014)
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma
A. Raiola et al.
BONE MARROW TRANSPLANTATION (2014)
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
L. Castagna et al.
BONE MARROW TRANSPLANTATION (2014)
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Peter Lang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Christopher G. Kanakry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Immunological outcome in haploicentical-HSC transplanted patients treated with IL-10-anergizec donor T Cells
Rosa Bacchetta et al.
FRONTIERS IN IMMUNOLOGY (2014)
Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma
Jennifer A. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation
Duncan Ross et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Partially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific Antibodies
Douglas E. Gladstone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Jennifer A. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies
Paolo Di Bartolomeo et al.
BLOOD (2013)
Depletion of T-cell receptor alpha/beta and CD 19 positive cells from apheresis products with the CliniMACS device
Michael Schumm et al.
CYTOTHERAPY (2013)
T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
Asad Bashey et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
W. Scheper et al.
LEUKEMIA (2013)
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Christopher G. Kanakry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome
Joseph Leventhal et al.
TRANSPLANTATION (2013)
Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Stefan O. Ciurea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation
Ming-Rui Huo et al.
CLINICAL TRANSPLANTATION (2012)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation
Joseph Leventhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
New Approaches to Graft Engineering for Haploidentical Bone Marrow Transplantation
Rupert Handgretinger
SEMINARS IN ONCOLOGY (2012)
Selective T-Cell Depletion for Haplotype-Mismatched Allogeneic Stem Cell Transplantation
Jean-Philippe Bastien et al.
SEMINARS IN ONCOLOGY (2012)
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Leo Luznik et al.
SEMINARS IN ONCOLOGY (2012)
Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
Kyoo-Hyung Lee et al.
BLOOD (2011)
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing
Dolores Grosso et al.
BLOOD (2011)
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
Claudio G. Brunstein et al.
BLOOD (2011)
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
James M. Coghill et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
Ashley Munchel et al.
PEDIATRIC REPORTS (2011)
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
Yvette L. Kasamon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Thomas Klingebiel et al.
BLOOD (2010)
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease
Jean-Philippe Bastien et al.
BLOOD (2010)
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
Leo Luznik et al.
BLOOD (2010)
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation
Xiao-Jun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: Long-term comparison with HLA-identical sibling transplantation
Xing-Hua Chen et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Antitumor Activity of γδ T Cells Reactive against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model
Christel Devaud et al.
CANCER RESEARCH (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.
Luca Vago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation
Stefan O. Ciurea et al.
TRANSPLANTATION (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
Lauri M. Burroughs et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children
Daihong Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
Fabio Ciceri et al.
BLOOD (2008)
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update
Wolfgang A. Bethge et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Sirolimus in unmanipulated haploidentical cell transplantation
L. von Reyn Cream et al.
BONE MARROW TRANSPLANTATION (2008)
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis
Hiroyasu Ogawa et al.
EXPERIMENTAL HEMATOLOGY (2008)
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia et al.
BLOOD (2007)
Skewed T cell receptor repertoire of Vδ1+ γδ T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction
N. Fujishima et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions
Xiao-Jun Huang et al.
TRANSPLANT IMMUNOLOGY (2007)
Partially matched, nonmyeloablative allogeneic transplantation: Clinical outcomes and immune reconstitution
David A. Rizzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J. Amrolia et al.
BLOOD (2006)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies
SQ Ji et al.
BONE MARROW TRANSPLANTATION (2005)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients
J Mehta et al.
BONE MARROW TRANSPLANTATION (2004)
Canadian multicenter pilot trial of haploidentical donor transplantation
I Walker et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults
EK Waller et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Long-term outcome after haploidentical stem cell transplantation in children
P Lang et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion
HR Chen et al.
EXPERIMENTAL HEMATOLOGY (2003)
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion:: an excellent alternative for high-risk leukemia
SQ Ji et al.
BONE MARROW TRANSPLANTATION (2002)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells
M Guimond et al.
BLOOD (2002)
Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process
BJ Chen et al.
BLOOD (2002)
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation
L Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide
L Luznik et al.
BLOOD (2001)
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants
I Volpi et al.
BLOOD (2001)
Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response
LS Lamb et al.
BONE MARROW TRANSPLANTATION (2001)
Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question
EJ Suchin et al.
JOURNAL OF IMMUNOLOGY (2001)
Adoptively transferred γδ T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice
WR Drobyski et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
